Evidence map›Paper›PMID 38361537›Full record

ReviewGerms2023

Endophthalmitis caused by

Stylianos A Kandarakis, Nikolaos Spernovasilis, Ilias Georgalas, Michalis Mendris, Constantinos Tsioutis, Aris P Agouridis

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Germs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Stylianos A KandarakisMD, PhD, Department of Ophthalmology, National and Kapodistrian University of Athens, 1 University Eye Clinic, G. Gennimatas General Hospital, 11527 Athens, Greece.
Nikolaos SpernovasilisMD, MPH, PhD, Department of Infectious Diseases, German Oncology Center, 4108 Limassol, Cyprus and School of Medicine, University of Crete, 71303 Heraklion, Crete, Greece.
Ilias GeorgalasMD, PhD, Department of Ophthalmology, National and Kapodistrian University of Athens, 1 University Eye Clinic, G. Gennimatas General Hospital, 11527 Athens, Greece.
Michalis MendrisMD, Department of Microbiology, Limassol General Hospital, 4131 Limassol, Cyprus.
Constantinos TsioutisMD, PhD, School of Medicine, European University Cyprus, 2410 Nicosia, Cyprus.
Aris P AgouridisMD, MSc, PhD, Assistant Professor of Internal Medicine/Pathophysiology, School of Medicine, European University Cyprus, 2410 Nicosia, Cyprus and Department of Internal Medicine, German Oncology Center, 4108 Limassol, Cyprus.
European University Cyprus · CYNational and Kapodistrian University of Athens · GRLimassol General Hospital · CYUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: A thorough search of PubMed, PubMed Central, and Scopus databases was conducted, covering the period up to October 2022. Results: A total of 53 records were identified, with 8 studies reporting a total of 21 cases meeting the inclusion criteria. Among these studies, 7 described isolated case reports, while 1 study described 14 cases. The overall quality of the reports was good, as all articles were determined to have low risk of bias. Vancomycin susceptibility was reported in only one case of isolated case reports, while the remaining cases were all vancomycin resistant. With regard to management, in most cases intravenous ampicillin and linezolid were administered, while only one study reported administration of vancomycin. Conclusions: Ophthalmologists should be aware of the potential for

Indexed as

endophthalmitisEnterococcus casseliflavusresistancesystematic reviewvancomycin

Identifiers

PMID38361537
PMCPMC10866162
OpenAlexW4391792514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.